Stifel raised the firm’s price target on Elanco (ELAN) to $16 from $15 and keeps a Buy rating on the shares. Revisiting Q1 earnings reports across Animal Health, Dental and Sleep Apnea, the firm says that in Animal Health it continues to believe the best risk/reward resides with Elanco and argues the stock’s growth algorithm “warrants a higher multiple.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAN:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue